BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000236 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
76,452
Total Value
$2,952,480.64
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 25,484 | $48.45 | $1,234,699.80 | 32,949 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Sale | 14,584 | $67.08 | $978,284.51 | 18,365 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Sale | 10,900 | $67.84 | $739,496.33 | 7,465 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Exercise/Conversion | 25,484 | $0.00 | $0.00 | 0 | Direct | โ | View Details |